Pentacyclic triterpenoids as potential ACL inhibitors from the rare medicinal plant Semiliquidambar cathayensis

被引:1
作者
Wu, Yu-Fei [1 ]
Zhao, Ze-Yu [1 ,2 ]
Yang, Min-Jie [3 ]
He, Yu-Hang [1 ]
Zang, Yi [4 ]
Li, Jia [4 ]
Hu, Jin-Feng [2 ]
Xiong, Juan [1 ]
机构
[1] Fudan Univ, Sch Pharm, Dept Nat Med, Shanghai 201203, Peoples R China
[2] Taizhou Univ, Inst Nat Med & Hlth Prod, Sch Pharmaceut Sci, Zhejiang Prov Key Lab Plant Evolutionary Ecol & Co, Zhejiang 318000, Peoples R China
[3] Fudan Univ, Huashan Hosp, Dept Emergency Med, Shanghai 200040, Peoples R China
[4] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Semiliquidambar cathayensis; Triterpenoids; Semiliquidacids; ACL (ATP-citrate lyase) inhibitor; Molecular docking; ATP-CITRATE-LYASE; BEMPEDOIC ACID; CONSTITUENTS; SAPONINS; LUPANE; PART; ROOT;
D O I
10.1016/j.fitote.2024.106018
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
An extensive phytochemical investigation on the rare medicinal plant Semiliquidambar cathayensis (family: Hamamelidaceae) led to the isolation of four new (1-4, 1 - 4 , named semiliquidacids A-D, respectively) and 25 related known pentacyclic triterpenoids. The new structures with absolute configurations were elucidated by spectroscopic methods, electronic circular dichroism (ECD) calculations, and single-crystal X-ray diffraction analysis. Compound 1 represents the first naturally occurring ursane-type triterpenoid featuring an uncommon C-25 formyl group. Compound 4 and oleanolic acid (13) 13 ) exhibited remarkable inhibitory effects against the ATP- citrate lyase (ACL, an emerging drug target for hyperlipidemia and related metabolic disorders) with IC50 50 values of 6.5 and 11.9 mu M, respectively. The molecular interaction and binding mode between the bioactive triterpenoids and ACL were elaborated by conducting a molecular docking study. Meanwhile, the chemotaxonomic significance of the isolated triterpenoids has been briefly discussed.
引用
收藏
页数:10
相关论文
共 65 条
[1]  
AHMAD VU, 1992, PHYTOCHEMISTRY, V31, P1051, DOI 10.1016/0031-9422(92)80073-N
[2]  
[Anonymous], 2000, The Central People"s Government of the People"s Republic of China
[3]   A bioactive triterpene from Lantana camara [J].
Barre, JT ;
Bowden, BF ;
Coll, JC ;
DeJesus, J ;
DelaFuente, VE ;
Janairo, GC ;
Ragasa, CY .
PHYTOCHEMISTRY, 1997, 45 (02) :321-324
[4]   TRITERPENOIDS .37. STRUCTURE AND STEREOCHEMISTRY OF LANTANOLIC ACID - NEW TRITERPENOID FROM LANTANA-CAMARA [J].
BARUA, AK ;
CHAKRABARTI, P ;
DUTTA, SP ;
MUKHERJEE, DK ;
DAS, BC .
TETRAHEDRON, 1971, 27 (06) :1141-+
[5]   Lipogenesis inhibitors: therapeutic opportunities and challenges [J].
Batchuluun, Battsetseg ;
Pinkosky, Stephen L. ;
Steinberg, Gregory R. .
NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (04) :283-305
[6]  
Bilia AR., 1996, PHARM ACTA HELV, V71, P191, DOI 10.1016/0031-6865(96)00010-6
[7]   Cytotoxic triterpenes from the aerial roots of Ficus microcarpa [J].
Chiang, YM ;
Chang, JY ;
Kuo, CC ;
Chang, CY ;
Kuo, YH .
PHYTOCHEMISTRY, 2005, 66 (04) :495-501
[8]   Triterpene phytoalexins from nectarine fruits [J].
El Lahlou, H ;
Hirai, N ;
Tsuda, M ;
Ohigashi, H .
PHYTOCHEMISTRY, 1999, 52 (04) :623-629
[9]  
esperion, 2023, Esporine Compony
[10]   ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: An updated review [J].
Feng, Xiaojun ;
Zhang, Lei ;
Xu, Suowen ;
Shen, Ai-zong .
PROGRESS IN LIPID RESEARCH, 2020, 77